Abstract
The invention relates to compounds or pharmaceutically acceptable salts thereof, compositions containing them, including combinations with at least one additional therapeutic agent, and their use in therapy, for example in the treatment of infectious diseases or in the treatment of diseases caused by Cryptosporidium.
Original language | English |
---|---|
Patent number | WO 2023/209336 A1 |
IPC | A61K31/519, A61P33/02,C07D487/04 |
Priority date | 26/04/22 |
Filing date | 20/04/23 |
Publication status | Published - 2 Nov 2023 |